TKIsselpercatinibcabozantinibvandetanibNew England Journal of MedicineClinical Cancer ResearchMedullary thyroid cancer (MTC)EACRIUC-DenverGFRA4+1 more
…r metastatic MTC. In the setting of progressive metastatic MTC, TKIs (selpercatinib, cabozantinib and vandetanib) can prolong surviv…